Design of a complete synthetic peptide-based AIDS vaccine with a built-in adjuvant.
Nardelli
B
B
Rockefeller University, New York, NY 10021.
Defoort
J P
JP
Huang
W
W
Tam
J P
JP
D016915:AIDS Vaccines / Q000008:administration & dosage / Q000276:immunology; D000276:Adjuvants, Immunologic; D000595:Amino Acid Sequence; D000818:Animals; D015483:HIV Antibodies / Q000096:biosynthesis; D015699:HIV Envelope Protein gp120 / Q000276:immunology*; D007156:Immunologic Memory; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008081:Liposomes; D051379:Mice; D008807:Mice, Inbred BALB C / Q000276:immunology; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000276:immunology*; D011107:Polylysine; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014611:Vaccination / Q000379:methods; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology
D016915:AIDS Vaccines; D000276:Adjuvants, Immunologic; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; C059762:HIV envelope protein gp120 (305-321); D008081:Liposomes; D010446:Peptide Fragments; D014614:Vaccines, Synthetic; D011107:Polylysine